US IN

(888) 440-0954

Home  |   Press  |  MedGenome to discuss its proprietary cancer immunotherapeutics platform

MedGenome to discuss its proprietary cancer immunotherapeutics platform

OncoPept is an integrated platform that interrogates tumor and its microenvironment to discover potential cancer vaccine candidates as therapeutics and biomarkers of response.

Considering genomic research?

We’re at your service

*
 
*
*